CoChat
Sign Up
Cited by 357Bladder and Urothelial Cancer TreatmentsGlobal Cancer Incidence and ScreeningUrinary and Genital Oncology Studies

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

The global burden of urinary bladder cancer

Parkin, D. Maxwell·2008·Scandinavian Journal of Urology and Nephrology
DOI 10.1080/03008880802285032
Open this paper in CoChat — free account

Abstract

Statistics on the incidence of bladder cancer are particularly hard to interpret, because of changing classification, variations in counting of multiple cancers in the same individual and, most importantly, the variable inclusion of non-invasive cancers in different data sets. Mortality statistics are almost certainly more comparable, but as indirect estimators of disease risk, require some cautious interpretation, because of differing survival between populations, and over time. Cancer of the bladder is estimated to be the ninth most common cause of cancer worldwide (357 000 cases in 2002) and the 13th most numerous cause of death from cancer (145 000 deaths). Rates in males are three to four times those in females. Incidence rates are high in many southern and eastern European countries, in parts of Africa and the Middle East, and in North America. The highest estimated mortality is in Egypt, where rates are more than three times greater than the highest rates in Europe and eight times those in the USA. In the USA, the incidence in whites is higher than in blacks. In general, in Western countries, incidence rates have been rising, but the increase has slowed or stopped in many. Mortality rates are, for the most part, decreasing. Trends are more variable in developing countries. To some extent, the geography and time trends are related to prevalence of known risk factors, especially exposure to tobacco (responsible for almost one-third of bladder cancer deaths) and, in some specific areas, schistosomiasis.

Overview

Integrity signals

Registry

Crossref · 10.1080/03008880802285032

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 15

  1. Parkin DM, 1994, Comparability and quality control in cancer registration. IARC Technical Report No 19
  2. World Health Organization, Table 3: Estimated completeness of mortality data for latest year
  3. Puffer RR, 1967, Patterns of urban mortality. Scientific Publication No 151
  4. Ferlay J, 2004, IARC Cancer Base No 5
  5. Curado MP, 2007, IARC Scientific Publications No 160
  6. Parkin D, 2005, IARC CancerBase No 7
  7. World Health Organization, Mortality database
  8. Karim-Kos HE, Eur J Cancer Feb 13, 2008 (epub ahead of print)
  9. 2004, Tobacco smoke and involuntary smoking, 83
  10. La Vecchia C, 1999, IARC Sci Publ, 139
  11. Blot WJ, 1978, J Natl Cancer Inst, 61, 1017
  12. 1994, Schistosomes, liver flukes and Helicobacter pylori, 61
  13. Utroska JA, 1989, An estimate of global needs for praziquantel within schistosomiasis control programmes. WHO/SCHISTO/89.102
  14. Miller BA, 1996, NIH Publication No 96-4104
  15. Yu MC, 1995, Cancer Epidemiol Biomarkers Prev, 4, 861

Cited by

Sorted by citations

See all 357

Related

Metadata

Authors
Parkin, D. M.
Affiliations
University of Oxford (GB)
Corresponding author
Parkin, D. Maxwell
ORCID
Parkin, D. Maxwell
Venue
Scandinavian Journal of Urology and Nephrology
Publisher
Informa UK Limited
Published
2008-01-01
Volume
42
Issue
sup218
Pages
12-20
ISSN
  • 0036-5599 (ISSN-L)
  • 1651-2065
DOI
10.1080/03008880802285032
OpenAlex
W2117705442
Cited by
357
References
40
Citations by year
2026: 2 · 2025: 8 · 2024: 9 · 2023: 8 · 2022: 18 · 2021: 16 · 2020: 10 · 2019: 14 · 2018: 16 · 2017: 29 · 2016: 24 · 2015: 25 · 2014: 31 · 2013: 33 · 2012: 33
FWCI
4.57
Type
journal article
Language
en
Open access
closed
Locations
  • Scandinavian Journal of Urology and Nephrology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Surgery › Urinary and Genital Oncology Studies
Keywords
bladder cancer, global burden of disease, cancer incidence, cancer mortality, incidence trends, mortality trends, sex differences, regional variation, tobacco smoke exposure, schistosomiasis, risk factors, non-invasive bladder cancer
MeSH terms
Urinary Bladder Neoplasms, Humans, Morbidity, Risk Factors, Global Health, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review